160 related articles for article (PubMed ID: 25688508)
1. Hypoxia-inducible factor-1α G polymorphism and the risk of cancer: a meta-analysis.
Ye Y; Wang M; Li J; Shi Y; Zhang X; Zhou Y; Zhao C; Wen J
Tumori; 2014; 100(6):e257-65. PubMed ID: 25688508
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α P582S and A588T polymorphisms and digestive system cancer risk-a meta-analysis.
Yang X; Zhang C; Zhu HC; Qin Q; Zhao LJ; Liu J; Xu LP; Zhang Q; Cai J; Ma JX; Cheng HY; Sun XC
Tumour Biol; 2014 Mar; 35(3):2825-30. PubMed ID: 24293391
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor-1α rs11549465 C>T and rs11549467 G>A gene polymorphisms are associated with an increased risk of digestive cancers in Asians.
Wang W; Wu BQ; Chen GB; Zhou Y; Li ZH; Zhang JL; Ding YL; Zhang P; Wang JQ
J Cancer Res Ther; 2018; 14(Supplement):S46-S53. PubMed ID: 29578149
[TBL] [Abstract][Full Text] [Related]
4. Association between HIF-1α C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studies.
Yan Q; Chen P; Wang S; Liu N; Zhao P; Gu A
BMC Cancer; 2014 Dec; 14():950. PubMed ID: 25496056
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α -1790G>A polymorphism significantly increases the risk of digestive tract cancer: a meta-analysis.
Sun X; Liu YD; Gao W; Shen SH; Li M
World J Gastroenterol; 2015 Feb; 21(5):1641-9. PubMed ID: 25663785
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis.
Zhao T; Lv J; Zhao J; Nzekebaloudou M
J Exp Clin Cancer Res; 2009 Dec; 28(1):159. PubMed ID: 20035632
[TBL] [Abstract][Full Text] [Related]
7. Association of hypoxia-inducible factor-1 alpha gene polymorphism with renal cell carcinoma susceptibility.
Huang L; Li MQ; Ou C; Huang WC; Liu JF; Huang H
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1105-S1109. PubMed ID: 30539853
[TBL] [Abstract][Full Text] [Related]
8. Common polymorphisms in the HIF-1α gene confer susceptibility to digestive cancer: a meta-analysis.
Xu JJ; Zou LY; Yang L; He XL; Sun M
Genet Mol Res; 2014 Aug; 13(3):6228-38. PubMed ID: 25158249
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1α C1772T polymorphism and cancer risk: a meta-analysis including 18,334 subjects.
Ye Y; Wang M; Hu S; Shi Y; Zhang X; Zhou Y; Zhao C; Wang G; Wen J; Zong H
Cancer Invest; 2014 May; 32(4):126-35. PubMed ID: 24576222
[TBL] [Abstract][Full Text] [Related]
10. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
11. Association of hypoxia-inducible factor-1α (HIF1α) 1790G/A gene polymorphism with renal cell carcinoma and prostate cancer susceptibility: a meta-analysis.
Li HY; Zhou T; Lin W; Lin S; Zhong H
BMC Med Genet; 2019 Aug; 20(1):141. PubMed ID: 31419966
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α 1772 C/T and 1790 G/A polymorphisms are significantly associated with higher cancer risk: an updated meta-analysis from 34 case-control studies.
Yang X; Zhu HC; Zhang C; Qin Q; Liu J; Xu LP; Zhao LJ; Zhang Q; Cai J; Ma JX; Cheng HY; Sun XC
PLoS One; 2013; 8(11):e80396. PubMed ID: 24260383
[TBL] [Abstract][Full Text] [Related]
13. Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.
Kuo WH; Shih CM; Lin CW; Cheng WE; Chen SC; Chen W; Lee YL
Transl Res; 2012 Jan; 159(1):42-50. PubMed ID: 22153809
[TBL] [Abstract][Full Text] [Related]
14. HIF-1α C1772T polymorphism and gastrointestinal tract cancer risk: a meta-analysis and meta-regression analysis.
Xu J; Xu L; Li L; You Q; Cha L
Genet Test Mol Biomarkers; 2013 Dec; 17(12):918-25. PubMed ID: 24063654
[TBL] [Abstract][Full Text] [Related]
15. Association between HIF1A P582S and A588T polymorphisms and the risk of urinary cancers: a meta-analysis.
Li D; Liu J; Zhang W; Ren J; Yan L; Liu H; Xu Z
PLoS One; 2013; 8(5):e63445. PubMed ID: 23723982
[TBL] [Abstract][Full Text] [Related]
16. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma.
Shieh TM; Chang KW; Tu HF; Shih YH; Ko SY; Chen YC; Liu CJ
Oral Oncol; 2010 Sep; 46(9):e47-53. PubMed ID: 20656543
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of developing digestive tract cancer in subjects carrying the PLCE1 rs2274223 A>G polymorphism: evidence from a meta-analysis.
Zhang X; Zhang Y; Gu D; Cao C; Zhang Q; Xu Z; Gong Y; Chen J; Tang C
PLoS One; 2013; 8(10):e76425. PubMed ID: 24116107
[TBL] [Abstract][Full Text] [Related]
18. HIF1A gene Pro582Ser polymorphism and susceptibility to digestive tract cancers: a meta-analysis of case-control studies.
Xu J; Xu L; Li LT; You Q; Cha LS
Genet Mol Res; 2014 Jul; 13(3):5732-44. PubMed ID: 25117331
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-1α polymorphisms and risk of cancer metastasis: a meta-analysis.
Zhang Q; Chen Y; Zhang B; Shi B; Weng W; Chen Z; Guo N; Hua Y; Zhu L
PLoS One; 2013; 8(8):e70961. PubMed ID: 24015181
[TBL] [Abstract][Full Text] [Related]
20. Relationship between CCR2-V64I polymorphism and cancer risk: a meta-analysis.
Huang Y; Chen H; Wang J; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Jul; 524(1):54-8. PubMed ID: 23612252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
